Notably, metabolic abnormalities (TG, blood glucose) and systemic inflammation (ESR, CRP) are the most important predictive factors, which is consistent with clinical association analysis, providing clues for understanding the biological mechanisms of RA-squamous cell lung cancer association. This evidence concerns the gene CRP and rheumatoid arthritis.